Introduction
T he prevalence of type 2 diabetes mellitus is increasing and the social and economic burden of this disease grows rapidly. 1, 2 Hospital inpatient care and drug treatment are two major cost drivers in diabetes care. Diabetes patients have on average 2.3 times higher medical expenditures compared with persons without diabetes. 3 After onset of type 2 diabetes a guideline adherent and structured treatment of the disease is seen as the best strategy for the prevention of diabetic complications such as diabetic retinopathy, nephropathy and neuropathy or cardiovascular and cerebrovascular diseases. A variety of disease management programmes (DMPs) have been introduced to assure coordinated health care and better guideline adherence in treatment. The implementation of nationwide mandatory DMPs by statutory public health insurances may have led to increasing bureaucracy rather than to an improvement in patient care. 4, 5 Current best evidence on DMPs demonstrated little effect on patient care, especially regarding clinically relevant endpoints. [6] [7] [8] [9] [10] [11] [12] [13] One of the drawbacks of DMPs may be the lack of active components that aim at an increase in patients' physical activity or lifestyle change activities. As lifestyle interventions like increased physical activity, diet, and patient education are key components in diabetes care [14] [15] [16] [17] , DMPs should focus more intensively on these components. A Cochrane review on exercise in patients with type 2 diabetes showed that physical activity significantly reduced HbA1c by 0.62% (À16.72 mmol/mol). 18 Reduced caloric intake and increased physical activity led to weight loss and to a significant improvement of metabolic control and risk factor profile in the Look-AHEAD trial. 19 Patient education has been shown to improve metabolic control in several systematic reviews. 16, 17, 20 It is challenging to reorient health care towards health promotion. Recent studies have shown that structures to sustain work with lifestyle interventions in primary care are lacking and organizational support such as national guidelines should be considered. 21 An alternative might be to emphasize selfmanagement and peer-to-peer motivation instead of professionally dominated educational interventions. Peer support is defined as 'support from persons who have the same health condition as the people they assist and experience the same challenges of living with the same chronic condition'. 22 There are several models of peer support, ranging from professionally-led peer support groups to peer-led support groups, from face-to-face meetings to telephonebased, and internet-based peer support. 23 Peer support may provide benefits to patients with chronic diseases such as type 2 diabetes, heart disease and HIV/AIDS, but the findings are inconsistent and the evidence is limited. 23, 24 Some peer support studies for type 2 diabetes have shown benefits for participants on healthier eating habits [25] [26] [27] , health distress [27] [28] [29] , blood pressure, 30 BMI 25 or depression. 26 For all of these outcomes contradictory results have been found. 24 We have previously demonstrated that a group-based peer support programme as an additional component to a DMP in type 2 diabetes is feasible. 31 The effectiveness of group-based peer support in type 2 diabetes in primary care regarding improvements in metabolic control. 31, 32 and cost-effectiveness 33 is still unclear. This study aimed to explore if group-based peer support in general practice for patients with type 2 diabetes as an additional component to a DMP can reduce the number of prescribed drugs; hospital admissions; and length of hospital stay and therefore be a cost-effective model.
Methods

Study design
This is a post-hoc controlled study based on a secondary data analysis of a 24 months cluster randomized interventional trial (registered ISRCTN 10291077). This study was set in general practices in the province of Salzburg in Austria. General practitioners recruited participants with type 2 diabetes enrolled in the Austrian DMP 'Therapie-Aktiv'. A detailed description of the methodology is presented elsewhere. 31 The primary aim of our group-based peer support intervention was to increase physical activity and promote self-management education to improve metabolic control (change in HbA1c). 31 Briefly, the mean age in the intervention was 62.2 years and 63.6 years in controls. There were no relevant demographical differences at baseline. Our primary intention-to-treat population followed the CONSORT guidelines for the reporting of cluster randomized controlled trials. 34 Further details on baseline characteristics of patient populations are presented in Supplementary Table S1 . All patients willing to participate were included in the study after obtaining written informed consent according to the declaration of Helsinki. Our study protocol was approved by the ethics committee of the province of Salzburg on 24 February 2010.
Intervention
The group-based peer support self-management education programme comprised exercise elements and group meetings, cofacilitated by peer supporters and healthcare professionals. The intervention was carried out over a period of two years, from May 2011 to 2013 and consisted of four elements:
(1) Recruitment of peer supporters: general practitioners suggested peer supporters based on their own judgement. The research team contacted the suggested peer supporters to provide them with more information and to invite them to participate in the peer supporter training sessions. Peer supporters are nonprofessionals who have type 2 diabetes. The peer supporters' main tasks were organization of group meetings and exercise units as well as log of attendance, and facilitation of group discussions on diabetes related topics. Peer supporters were encouraged to give support e.g. to motivate group member to participate and support 'less' fit members. (2) Peer supporter training: during the first year of intervention peer supporters received six sessions of training (4 h each). We compiled a standardized curriculum for the training in order to assure reproducibility within the trial and for any application afterwards. Professionals trained peer supporters addressing the following topics: the concept of peer support, organization of group meetings, physical activity, recommendations for the treatment and management of type 2 diabetes, motivation, medical aspects of diabetes, nutrition, experience and feedback. (3) Physical exercise meetings: peer groups met once every week for at least one hour of physical outdoor activity such as walking combined with mobilization, coordination and strength training. The first meetings were facilitated by a physical education trainer to get the groups started and familiarize them with the intervention and exercises. Thereafter, groups met largely autonomously and trainers supported the groups only when needed. (4) Peer group meetings: once a month groups held conversational and educational meetings focusing on personal, social and emotional topics in the context of diabetes. The meetings were held at the general practitioner surgery or in seminar rooms and moderated alternately by peer supporters and health professionals (dietician, psychologist, general practitioner/internist, diabetes nurse and sports scientist). To assure standardization and coverage of the most important topics, health care professionals involved in the group meetings developed a curriculum. It guided participants through subject areas that alternated every other month and provided matched topics for every single session (Supplementary Table S2> ).
Patients in the control clusters received standard care according to the Austrian DMP 'Therapie-Aktiv', which included usual care according to international guidelines regarding diagnostics and treatment of diabetes.
Randomization
All participants were cluster-randomized by electronic sequence generation using Research Randomizer after completion of recruitment and allocation of patients to prospective peer groups as clusters. Clustering was performed by the study management grouping 8-12 participants living close to each other to facilitate face-to-face meetings.
Study size
Forty-nine of the 77 general practitioner surgeries (63.6%) administering the DMP 'Therapie-Aktiv' in the province of Salzburg recruited (September 2010-April 2011) patients for 'Aktivtreff Diabetes'. Our intention-to-treat-population (n = 328) of 'Aktivtreff Diabetes' involving 148 (19 groups) patients in the intervention group and 189 (20 groups) control patients was used for analysis. 31 Variables and data sources
Cost of intervention
Cost of delivering intervention included peer supporter training, physical educational trainers attending the physical exercise meetings, health care professionals attending the regular group meetings, personal travel expenses, peer supporter reimbursement and print material (peer supporter handbook, newsletters and exercise sheets). All of which were expressed in Euros, gross amounts. These data were mainly collected via our project accounting. The cost per supporter training session was based on actual salary and fringe of health care professionals responsible for the session (e.g. medical doctor, dietitian, physical educational trainer or psychologist). Details on the costs related to each session of the peer supporter training are listed in the Supplementary Table S3 . Physical educational trainers visiting the exercise meetings and health care professionals visiting the regular group meeting were reimbursed according to local professional fees. Travel expenses included per kilometre money (E0.42 per km) or car hire. Each peer supporter was reimbursed with E10 per physical exercise meeting.
Effectiveness and cost analysis
Anonymized data for effectiveness and cost analysis of 'Aktivtreff Diabetes' were collected through the Salzburg statutory health insurance (Salzburger Gebietskrankenkasse). Following data and outcome measures were collected via the subsequent costs database (FOlgeKOsten Datenbank, also known as FOKODatabase) at the statutory health insurance: number of prescribed drugs; costs of prescribed drugs; number of (all-cause) hospital admissions; and length of hospital stay in days. In the subsequent costs database drugs are defined as prescribed drugs obtained in a pharmacy. Data were only available for 'Aktivtreff Diabetes' participants insured by the Salzburg statutory health insurance. Information on prescribed drugs, cost of prescribed drugs, allcause hospital admissions and length of hospital stay were available as a total number in intervention and control groups and per single cluster (=group). Data analysis was performed on clusters and not by comparing individual patient data. Cluster data were collected between 1 May 2011 to 31 May 2013. This period covered the period when the intervention was carried out (May 2011 to May 2013). Only data in this period of time was considered for analysis. Hospital admission was defined as staying at a hospital for at least one night or more. Length of hospital stay was defined as the period of time a patient remains in a hospital as an inpatient. It is calculated from the day of admission to the day of discharge and is based on the number of nights spent in hospital. It was not possible to retrieve real data on hospital treatment costs. In this trial hospital treatment costs were estimated by taking the average cost of one treatment day in Austria multiplied with the total number of hospitalization days in each group separately. According to the Austrian Ministry of Health, in 2013 one hospital treatment day costed E922 (staying overnight). 35 
Statistical methods
All statistical analyses were performed with IBM SPSS Statistics 20.0. A per-protocol analysis was performed for all outcomes. On a cluster level, a descriptive and effectiveness analysis was performed based on data from the subsequent costs database (FOKO-database). Data were analysed per cluster, as total and means by comparing intervention and control groups. For unadjusted, univariate analysis, the independent t-test (two-tailed) was used to detect significant differences between the intervention and the control group. The MannWhitney U test was used on non-normal distributions to detect differences between groups.
Results
In total, 261 persons (79.6%) of our intention-to-treat-population (n = 328) were included in this secondary data analysis (Supplementary figure S1). Data were available of 118 (82.5%, 17 clusters) participants in the intervention group and of 143 (77.3%, 19 clusters) controls. A descriptive analysis of prescribed drugs and hospitalization is presented in table 1.
Intensity and costs of the intervention
The median number of physical activity meetings per group was 86 (1-104) with an achievable maximum of 104 times (once per week for two years). Physical education trainers supported the groups in 11% of all performed physical activity meetings (148 of 1344). In total, 178 group meetings were performed by the peer groups, of which 126 (72.4%) were supported by a professional. Total cost of implementing and maintaining 'Aktivtreff Diabetes'' during 24 months was E49 725.90. In our study population (n = 118), mean cost per patient and year was E210.70 (table 2) . Further details of costs related to peer supporter training and peer group meetings are available in the Supplementary Materials (tables 3 and 4).
Effectiveness and cost analysis
No significant differences between intervention and control groups during the 24-month study period were seen in the number of prescribed drugs, costs of prescribed drugs and number of allcause hospital admissions (table 3). The mean difference between groups regarding all-cause hospital admissions was a non-significant À1.82 admissions/patient (95% CI -6.07 to 2.44, P = 0.391, student t-test) in favour of the intervention group. The length of overall hospital stay was significantly shorter in the intervention groups compared with controls. The mean difference during the 24-month study period was À40.13 days (95% CI À78.54 to À1.71, P = 0.041, student t test) in favour of the intervention group. Legend: n, number of participants.
Estimated costs and savings per patient
Patients in the intervention group spent significantly less days in the hospital than patients in the control group. The estimated cost savings in favour of the intervention by reducing length of hospital stay during the 24 months intervention was E4241 per patient (95% CI E12 914-E8673). If we consider cost of intervention and prescribed drugs, the estimated yearly savings was E1660.60 per patient (table 4) .
Discussion
Despite large efforts to improve diabetes prevention and treatment, there are still substantial deficits in diabetes care. 36, 37 There is a strong demand for diabetes management optimizzation. A potentially low-cost, flexible compliment to formal health care services is group-based peer support. We have previously demonstrated that a group-based peer support intervention as an additional component to a traditional DMP on type 2 diabetes in primary care is feasible although it does not significantly influence metabolic control. 31 This secondary data analysis aimed to perform a cost analysis of 'Aktivtreff Diabetes' and to explore if a group-based peer support concept as an additional component to a DMP can reduce the number of prescribed drugs, hospital admissions and length of hospital stay, therefore being a cost-effective model. There was a trend when comparing clusters that ''Aktivtreff Diabetes'' reduced the number of all-cause hospital admissions. Patients in the intervention group spent significantly less days in a hospital compared with controls. No difference was seen in the number of prescribed drugs. The estimated yearly cost savings in favour of the intervention by reducing the length of hospital stay was E1660.60 per patient.
Comparison to other research
So far, little is known about the association of peer support in diabetes and its impact on hospitalizations and costs. One recently published study demonstrated that an intensive lifestyle intervention (specifically developed for type 2 diabetes patients) could reduce the number of hospital admissions and length of stay in hospitals which led to cost savings for hospitalization. 38 Further studies have shown that physical inactivity and type 2 diabetes are related to an increased likelihood of all-cause hospitalization. 39 Physical inactivity in elderly is associated with increased hospital admissions, length of stay and healthcare expenses. 40 To our knowledge, only one study has performed a cost-effectiveness analysis of a group-based peer support programme in type 2 diabetes. Gillespie et al. 33 demonstrated that the 24 months intervention was associated with a reduction in mean health care costs of E560 (95% CI À1738.89 to 618.73) per patient. The total cost of the intervention was E54 457, giving a mean cost per patient of E246. This is in line with the costs of 'Aktivtreff Diabetes', E49 725.90 (E210.70 per patient).
Strengths and limitations
This is a post-hoc study based on a secondary data analysis of a 24 months cluster randomized interventional trial. The study protocol presented to the ethics committee of the province of Salzburg included a cost analysis, however not on an individual basis. This is the reason why our cost analysis was performed on clusters and not on individuals. It was not possible to use real patient data to explore hospitalization costs. To analyse hospitalization costs the average cost of one hospital treatment day in Austria was used (E922 in 2013). 35 Our estimated hospitalization costs may be undervalued as we know diabetes patients have on average higher medical expenditures than patients without diabetes. 3 In our cost of intervention analysis we focussed on direct costs. Costs related to physician and patient recruitment, travelling costs of patients, was not considered in this analysis. Costs related to project management, development of the peer support concept and study material were also not taken into consideration.
Our trial is characterized by a high level of internal validity, however some risk of bias remains. The recruitment of patients was done by physicians and patient selection may not have been free of bias as concealment of allocation was done at the physician level, but not at the patient recruitment level. To eliminate this risk of bias in our main trial we performed a cluster randomization on the physician level. 31 A selection bias could have occurred due to physicians' selection of patients. We suspect that preferably 'healthy' participants were recruited for our trial (HbA1c at baseline was 7.0%). Thus, patients with higher HbA1c values may have been less motivated and less compliant despite their greater potential for improvement by participating in a group-based peer support programme. Because this was a 'pragmatic' study, a disproportionate recruitment of 'healthy' patients may reflect real life, with recalcitrant cases not opting in for such programmes as peer support. On the other side we believe, that our intervention would have been even more effective if we had targeted diabetes patients with higher HbA1c values (e.g. patient inclusion criteria HbA1c ! 8%). It should also be mentioned that the attendance rates of the group sessions in our study were good but not excellent and the intensity of the intervention might have been too low. Due to withdrawal of consent, some groups were smaller than planned with a potentially negative impact on group dynamics. Regarding generalizability, the external validity of our results may be limited. In total, 49 of 77 eligible Salzburg province physicians recruited patients for the study. All patients in this study were involved in the Austrian DMP 'Therapie-Aktiv'. The results of our study may not easily be transferable to the Austrian or European population as a whole. The diabetes prevalence in Salzburg is slightly lower than in the rest of the country, due to unknown reasons. The effect of 'Aktivtreff Diabetes' on population health in our study may therefore be different and maybe less than the effect in a population with higher diabetes prevalence or in patients with poor glycaemic control.
Conclusion
A group-based peer support programme is a promising approach that could strengthen lifestyle interventions in DMPs for type 2 diabetes patients. Peer support seems to reduce length of hospital stay and could therefore be a cost-effective model. A long-term RCT with hospitalization as primary endpoint is necessary to confirm these findings.
Supplementary data
Supplementary data are available at EURPUB online. 
Keypoints
A group-based peer support as an additional component of diabetes disease management programmes was identified as organizational support that could enhance work with lifestyle interventions in primary health care. A group-based peer support programme is a low-cost model that can improve diabetes care and enhance patient empowerment. We estimate that hospitalization cost can be reduced by a group-based peer support programme as length of hospital stay was shorter in the intervention group compared with controls.
